Blog
RSS FeedPosted by Michael Wonder on 17 May 2024
Efanesoctocog alfa for the treatment and prevention of bleeding episodes in patients with haemophilia A
17 May 2024 - The Department of Health and Social Care has asked NICE to produce guidance on the use ...
Posted by Michael Wonder on 17 May 2024
Chemists to lose dollar discount option as government bows to Pharmacy Guild pressure
16 May 2024 - Chemist Warehouse will be stripped of its ability to give its customers $1 off their medicines, ...
Posted by Michael Wonder on 16 May 2024
Delegation from Taiwan visits IQWiG
15 May 2024 - At the end of April 2024, Mao-Ting Sheen visited the Institute for Quality and Efficiency in Healthcare ...
Posted by Michael Wonder on 16 May 2024
Tisagenlecleucel for the treatment of patients with relapsed or refractory B-cell acute lymphoblastic leukaemia
15 May 2024 - NICE has published final evidence-based recommendations on the use of tisagenlecleucel (Kymriah) for the treatment of ...
Posted by Michael Wonder on 16 May 2024
Acceptability of using real world data to estimate relative treatment effects in health technology assessments: barriers and future steps
15 May 2024 - Evidence about the comparative effects of new treatments is typically collected in randomised controlled trials (RCTs). In ...
Posted by Michael Wonder on 16 May 2024
Selinexor in combination with bortezomib and dexamethasone for the treatment of patients with relapsed/refractory multiple myeloma (final guidance)
15 May 2024 - NICE has published final evidence-based recommendations on the use of selinexor (Nexpovio) in combination with bortezomib ...
Posted by Michael Wonder on 16 May 2024
It is time to reconsider the 3% discount rate
15 May 2024 - Health technology assessment guidance often recommends a 3% real annual discount rate, the appropriateness of which ...
Posted by Michael Wonder on 15 May 2024
Atogepant monohydrate for the prevention of migraine
15 May 2024 - NICE has published final evidence-based recommendations on atogepant monohydrate (Aquipta) for preventing migraine in adults. ...
Posted by Michael Wonder on 14 May 2024
Budget 2024–25: cheaper medicines, new Medicare Urgent Care Clinics and more free mental health services in a stronger Medicare
14 May 2024 - The Albanese Labor Government is continuing to improve our health system: strengthening Medicare, the heart of universal ...
Posted by Michael Wonder on 14 May 2024
SMC - May 2024 decisions
13 May 2024 - The SMC has today published advice on two medicines. ...
Posted by Michael Wonder on 13 May 2024
PHARMAC shares the agenda items for the upcoming Rare Disorders Committee meeting (May 2024)
13 May 2024 - PHARMAC is sharing what medicine applications will be considered at the Rare Disorders Advisory Committee meeting ...
Posted by Michael Wonder on 13 May 2024
First ever life-saving treatment for rare heart condition available on the NHS
13 May 2024 - NHS patients with a life-threatening heart condition are set to benefit from a cutting-edge new medicine ...
Posted by Michael Wonder on 13 May 2024
Remdesivir and the combination of tixagevimab and cilgavimab for the treatment of patients with COVID-19 disease (final guidance)
8 May 2024 - NICE has published final evidence-based recommendations on the use of remdesivir (Veklury) and tixagevimab and cilgavimab ...
Posted by Michael Wonder on 13 May 2024
A systematic review on the appropriate discounting rates for the economic evaluation of gene therapies: whether a specific approach is justified to tackle the challenges
10 May 2024 - Discounting the cost and effect for health intervention is a controversial topic over the last two decades. ...
Posted by Michael Wonder on 13 May 2024
Australians benefit from new life changing medicines added to the PBS
13 May 2024 - Women with endometrial cancer and people with itching associated with chronic kidney disease will benefit from ...